Influence of circulating c-erbB-2 serum protein on response to adjuvant chemotherapy in node-positive breast cancer patients

By Fehm T.  

Breast Cancer Research and Treatment, Vol. 43, Iss. 1, 1997-03 ,pp. : 87-95

Springer Publishing Company

Access to resources Recommend Favorite

Plasma c-erbB2 Concentrations in Relation to Chemotherapy in Breast Cancer Patients

By Revillion F.   Hebbar M.   Bonneterre J.   Peyrat J.P.  

European Journal of Cancer, Vol. 32, Iss. 2, 1996-02 ,pp. : 231-234

Elsevier

Access to resources Recommend Favorite

Overexpression of c-erbB-2 is related to a higher expression of vascular endothelial growth factor (VEGF) and constitutes an independent prognostic factor in primary node-positive breast cancer after adjuvant systemic treatment

By Linderholm B.   Andersson J.   Lindh B.   Beckman L.   Erlanson M.   Edin K.   Tavelin B.   Grankvist K.   Henriksson R.  

European Journal of Cancer, Vol. 40, Iss. 1, 2004-01 ,pp. : 33-42

Elsevier

Access to resources Recommend Favorite

C-erbB-2 expression does not predict response to docetaxel or sequential methotrexate and 5-fluorouracil in advanced breast cancer

By Sjostrom J.   Collan J.   von Boguslawski K.   Franssila K.   Bengtsson N.-O.   Mjaaland I.   Malmstrom P.   Ostenstad B.   Wist E.   Valvere V.   Bergh J.   Skiold-Petterson D.   Saksela E.   Blomqvist C.  

European Journal of Cancer, Vol. 38, Iss. 4, 2002-03 ,pp. : 535-542

Elsevier

Access to resources Recommend Favorite

C-erbB-2 overexpression and survival in early onset breast cancer

By Agrup M.  

Breast Cancer Research and Treatment, Vol. 63, Iss. 1, 2000-09 ,pp. : 23-29

Springer Publishing Company

Access to resources Recommend Favorite